Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1a615b6db0acb71ee30f71f157888ba2 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-12 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-02 |
filingDate |
2011-11-11^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a0e066f2accd3ce7b492101fd3dc5000 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c12c6815af885117b3514cdb7765cae2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4b746f8ee3e914b3a49f5469a77bcb50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bb7956cd585dca95b5964a77164730f2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d16ab1ef4dec38cc90397afffacc09e6 |
publicationDate |
2013-10-09^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-2646431-A1 |
titleOfInvention |
A process for the preparation of pazopanib using novel intermediate |
abstract |
The present invention provides a commercially viable process for preparing pazopanib and its pharmaceutically acceptable acid addition salts thereof in high yields using novel intermediate. The present invention also provides a process for the purification of pazopanib hydrochloride. |
priorityDate |
2010-11-29^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |